Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 2:14:1270296.
doi: 10.3389/fneur.2023.1270296. eCollection 2023.

Effectiveness of rehabilitation intervention in persons with Friedreich ataxia

Affiliations

Effectiveness of rehabilitation intervention in persons with Friedreich ataxia

Gabriella Paparella et al. Front Neurol. .

Abstract

Introduction: The relevance of rehabilitation in progressive neurological disorders, such as Friedreich's Ataxia (FRDA), has yet to be convincingly proven. FRDA is characterized by ataxia, loss of gait, scoliosis, cardiomyopathy, dysarthria and dysphagia, with reduced life expectancy. The disease onset is usually in adolescence, leading to progressive disability. Omaveloxolone has been recently approved as the first pharmacological treatment for FRDA in adults and adolescents aged 16 years and older. Regarding non-pharmacological therapies, neurorehabilitation is a valuable aid in addressing the symptoms and in maintaining the residual functioning. We performed a prospective observational cohort study to evaluate the efficacy of inpatient rehabilitation (IR) for people with FRDA.

Methods: A total of 42 individuals (29 adults and 13 children) with FRDA were recruited. There were 27 ambulant and 15 non-ambulant participants. The patients underwent IR of 3 and 4 weeks in children and adults, respectively. The IR treatment was designed to be applied within a multidisciplinary setting, so FRDA patients underwent, in addition to physiotherapy, also occupational therapy, practical manual activities and psychological support aiming to enhance transferable skills useful in the activities of daily living. The primary outcome was the Scale for the Assessment and Rating of Ataxia (SARA). Other measures were: Friedreich Ataxia Rating Scale (FARS) and Nine Hole Peg Test (NHPT). Furthermore, we used the 6 Minute Walk Test (6MWT), the Timed Up and Go (TUG) and the Berg Balance Scale (BBS) only on ambulant subjects. Outcomes were evaluated at baseline and at the end of the treatment.

Results: We report that the IR significantly improves motor performance and ataxia symptoms in patients with FRDA. Our study shows significant functional improvement in all the outcome measures used, except for NHPT bilaterally. FARS and SARA scores post-IR are significatively reduced when compared (p < 0.001).

Discussion: We demonstrate that IR programs in FRDA can provide a meaningful clinical improvement in terms of outcome measures. These findings could be useful when approaching progressive neurological disorders.

Keywords: Friedreich ataxia; adults; children; inpatients; rehabilitation; treatment outcome.

PubMed Disclaimer

Conflict of interest statement

NP collaborates with Revelo Datalabs Srl. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Study scheme. IR, inpatient rehabilitation.
Figure 2
Figure 2
Comparison of SARA, FARS Total, FARS LL, FARS UL and FARS US administered to the entire cohort of patients pre vs. post IR. LL, lower limb; UL, upper limb; US, upright stability. Sig: *** <0.001.
Figure 3
Figure 3
Comparison of NHPT in dominant and non-dominant hand administered to the entire cohort of patients pre vs. post IR. D, dominant hand; ND, non-dominant hand.
Figure 4
Figure 4
Comparison of 6MWT, BBS, and TUG administered only to ambulant patients pre vs. post IR. Sig: *** <0.001, ** <0.01.

References

    1. Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, et al. . Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. (1996) 271:1423–7. doi: 10.1126/science.271.5254.1423 - DOI - PubMed
    1. Maring JR, Croarkin E. Presentation and progression of Friedreich ataxia and implications for physical therapist examination. Phys Ther. (2007) 87:1687–96. doi: 10.2522/ptj.20060232, PMID: - DOI - PubMed
    1. Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Clinical features of Friedreich's ataxia: classical and atypical phenotypes. J Neurochem. (2013) 126:103–17. doi: 10.1111/jnc.12317, PMID: - DOI - PubMed
    1. Schulz JB, Boesch S, Bürk K, Dürr A, Giunti P, Mariotti C, et al. . Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. (2009) 5:222–34. doi: 10.1038/nrneurol.2009.26, PMID: - DOI - PubMed
    1. Dürr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, et al. . Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med. (1996) 335:1169–75. doi: 10.1056/NEJM199610173351601 - DOI - PubMed

LinkOut - more resources